US Securities and Exchange Commission+Income Loss From Continuing Operations Before Income Taxes Foreign+Karyopharm Therapeutics Inc.+2021 - Wikirate, an Open ESG Data Platform

Question: What is the company's portion of earnings or loss from continuing operations before income taxes?

Answer:

-30.1M

USD

WikiRate ID: 14243915

Metric Designer: US Securities and Exchange Commission

Metric Title: Income Loss From Continuing Operations Before Income Taxes Foreign

Company: Karyopharm Therapeutics Inc.

Year: 2021

Status:

Unverified - Added by Steward

updated over 1 year ago by Vasiliki Gkatziaki

Source

Comments